Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.24 | -$0.24 | -$0.24 |
Q2 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
Q3 2024 | 4 | -$0.44 | -$0.23 | -$0.34 |
Q1 2025 | 3 | -$0.40 | -$0.31 | -$0.36 |
Q2 2025 | 2 | -$0.30 | -$0.30 | -$0.30 |
Q3 2025 | 2 | -$0.30 | -$0.30 | -$0.30 |
Q4 2025 | 2 | -$0.32 | -$0.32 | -$0.32 |
Achieve Life Sciences, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.36 earnings per share for the quarter, missing analysts' consensus estimates of $-0.26 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Achieve Life Sciences, Inc. has generated $-2 earnings per share over the last year ($-1.5 diluted earnings per share) and currently has a price-to-earnings ratio of -3.85. Achieve Life Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.26 | -$0.36 | -0.1 | $0 | $0 |
08/13/2024 | Q2 2024 | -$0.22 | -$0.25 | -0.03 | $0 | $0 |
05/09/2024 | Q1 2024 | -$0.24 | -$0.26 | -0.02 | $0 | |
12/29/2023 | Q4 2023 | -$0.26 | $0 | |||
11/09/2023 | Q3 2023 | -$0.34 | -$0.34 | 0 | $0 | |
08/14/2023 | Q2 2023 | -$0.41 | -$0.43 | -0.02 | $0 | |
05/09/2023 | Q1 2023 | -$0.65 | -$0.53 | 0.12 | $0 | |
05/16/2023 | Q4 2022 | -$0.81 | $0 | |||
11/14/2022 | Q3 2022 | -$1.10 | -$1.40 | -0.3 | $62,500 | $0 |
08/11/2022 | Q2 2022 | -$0.79 | -$1.13 | -0.34 | $62,500 | $0 |
05/12/2022 | Q1 2022 | -$0.82 | -$0.84 | -0.02 | $0 | |
03/10/2022 | Q4 2021 | -$0.73 | -$0.76 | -0.03 | $0 | |
11/09/2021 | Q3 2021 | -$1.09 | -$0.71 | 0.38 | $0 | |
08/12/2021 | Q2 2021 | -$1.53 | $0 | |||
05/13/2021 | Q1 2021 | -$0.78 | -$1.30 | -0.52 | $0 | |
03/11/2021 | Q4 2020 | -$1.27 | -$0.77 | 0.5 | $0 | |
11/12/2020 | Q3 2020 | -$1.30 | -$1.14 | 0.16 | $0 | |
08/06/2020 | Q2 2020 | -$3.80 | -$1.68 | 2.12 | $0 | |
05/14/2020 | Q1 2020 | -$2.40 | -$2.15 | 0.25 | $0 | |
03/13/2020 | Q4 2019 | -$5.40 | -$5.91 | -0.51 | $0 |
Achieve Life Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
The conference call for Achieve Life Sciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Achieve Life Sciences, Inc.'s latest earnings report can be read online.
Achieve Life Sciences, Inc. (:ACHV) has a recorded net income of $0. Achieve Life Sciences, Inc. has generated $-1.5 earnings per share over the last four quarters.
Achieve Life Sciences, Inc. (:ACHV) has a price-to-earnings ratio of -3.85 and price/earnings-to-growth ratio is 2.14.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED